Zimbabwe has rejected a substantial US healthcare agreement valued at 367 million US dollars (£272m) spanning five years due to Washington's demand for sensitive information.
The decision became public following a government memo from December was leaked, revealing that President Emmerson Mnangagwa believed the deal was "lopsided".
A government representative later clarified that the US was requesting genetic material for scientific study and profit but was unwilling to guarantee the benefits from future medical innovations.
"We are forced to start the challenging and unfortunate task of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the US had furnished over $1.9bn in health funding to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has appealed for further dialogue to find a agreement suitable to both sides so the country's critical HIV treatment initiative can continue.
Wider Background
This rejection follows a similar situation in neighbouring Kenya, where a court blocked a related deal with the US following legal challenges were raised about the safety of Kenyans' health data.
After resuming the presidency recently, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.
USAID had administered assistance for the American government, but Trump argued its expenditure was "inefficient" and his administration was pursuing direct bilateral agreements to enhance transparency and accountability.
According to statements, Sixteen nations in Africa have to date signed these new agreements, constituting more than $18.3bn in committed funds.
Specifics of the Declined Agreement
This assistance for Zimbabwe would have funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this cooperation might have yielded immense advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy via US-supported programmes," the Ambassador added.
However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to surrender its biological resources and data for a long time, with no corresponding assurance of access to any medical innovations – like vaccines, diagnostics, or treatments – that could be developed from that shared data," his statement read.
"Put simply, our country would provide the raw materials for medical research without any certainty that the final treatments would be accessible to our citizens if a future disease outbreak arise."
National Interest and International Frameworks
He also pointed out that the US's withdrawal from the global health body and its push of bilateral health agreements were upending frameworks already established via the international organization.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme designed to manage future pandemics.
"This mechanism is designed to ensure that when a nation provides its information, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the capability to create them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as opposition to America," he added.
"We welcome ongoing discussions with our US partners on how future collaboration could be arranged in a manner that respects the independence and interests of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the official position, but urged that talks should continue given that much of the nation's Aids initiatives depended on foreign aid.
"Where technical issues exist, including those involving information security or implementation frameworks, these can often be addressed through detailed discussion and negotiated safeguards," the group added.
This impasse emphasises the complex debate between accepting crucial international aid and protecting local interests in an ever more interconnected world.